StockData
Zomedica Corp. logo

Zomedica Corp. (ZOMDF) stock

ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$0.08−0.00 (-0.55%)

Close on Oct 19, 2026Market cap $77.40MP/E –Yield –

Zomedica gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Zomedica's gross profit for the twelve months ending Jun 30, 2026 was $24.13M, up 22.6% year over year. For fiscal 2025 it was $21.68M, up 13.6% from the year before. The highest annual figure on record is $21.68M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$21.68M+13.6%
FY2024Dec 31, 2024$19.09M+10.2%
FY2023Dec 31, 2023$17.32M+28.6%
FY2022Dec 31, 2022$13.47M+341.0%
FY2021Dec 31, 2021$3.05M–
FY2020Dec 31, 2020$0–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.04M+29.5%
Q1 FY2026Mar 31, 2026$5.48M+24.4%
Q4 FY2025Dec 31, 2025$7.17M+29.2%
Q3 FY2025Sep 30, 2025$5.44M+7.4%
Q2 FY2025Jun 30, 2025$4.67M+7.0%
Q1 FY2025Mar 31, 2025$4.41M+7.0%
Q4 FY2024Dec 31, 2024$5.55M+9.4%
Q3 FY2024Sep 30, 2024$5.06M+16.0%
Q2 FY2024Jun 30, 2024$4.36M+7.8%
Q1 FY2024Mar 31, 2024$4.12M+7.4%
Q4 FY2023Dec 31, 2023$5.07M+20.5%
Q3 FY2023Sep 30, 2023$4.36M+24.2%
Q2 FY2023Jun 30, 2023$4.05M+34.7%
Q1 FY2023Mar 31, 2023$3.84M+40.0%
Q4 FY2022Dec 31, 2022$4.21M+37.6%
Q3 FY2022Sep 30, 2022$3.51M+70120.0%
Q2 FY2022Jun 30, 2022$3.01M–
Q1 FY2022Mar 31, 2022$2.74M+34150.0%
Q4 FY2021Dec 31, 2021$3.06M–
Q3 FY2021Sep 30, 2021$5.00K–
Q2 FY2021Jun 30, 2021-$20.00K–
Q1 FY2021Mar 31, 2021$8.00K–
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–

More Zomedica figures

See a number that looks wrong?